Multimodal AI Platform for Modality Agnostic Drug Discovery™
We are the only AI-native biotech pioneering small and large molecule therapeutics discovery by integrating massive multimodal data, frontier AI models, and high-throughput lab automation into an infrastructure for AI-enabled drug discovery.
What they do:
Artificial intelligence for drug discovery.
Quick facts:
HQ: San Francisco, CA, United States
Funding:
$19.8M · Equity · Mar 2026
What they do:
Altay develops disease-modifying therapies targeting transcription…
Quick facts:
HQ: San Francisco, CA, United States
Funding:
$15.7M · Equity · Oct 2026
What they do:
Medicinal Chemistry powered by Machine Learning
Quick facts:
HQ: Boston, MA, United States
What they do:
Empowering women. Period.
Quick facts:
HQ: San Francisco, CA, United States
What they do:
Using the immune system to cure disease
Quick facts:
HQ: San Francisco, CA, United States
What they do:
AI Inference Platform for Drug Discovery
Quick facts:
HQ: San Francisco, CA, United States
Multimodal AI Platform for Modality Agnostic Drug Discovery™
Boston, MA, United States
20 employees, according to the company profile.
There are no funding rounds for 1910 in our data.
Similar startups: Numerion Labs, Altay Therapeutics, and PostEra.